Rheumatology Practice Management October 2016 Vol 4 No 5

Physicians seem to have a natural affinity for complexity. That’s a good thing for patients with difficult diagnoses, but it’s a prescription for disaster when it comes to investing. Owning a myriad of securities spread across a dozen or more financial accounts usually means more taxes, more transaction costs, less clarity, and more time spent on investing. Read More ›

• Adalimumab Biosimilar Approved to Treat Multiple Indications
• First Drug for Duchenne Muscular Dystrophy Granted Accelerated Approval
• FDA Approves Etanercept Biosimilar for Multiple Indications

Read More ›

Mobile, AL—In a breakout session at the 2016 National Organization of Rheumatology Managers conference, Deborah Walker Keegan, PhD, FACMPE, Healthcare Business Consultant, Medical Practice Dimensions, Asheville, NC, shared 8 strategies that practice managers can use to expedite payments in today’s challenging medical reimbursement environment. Read More ›

The following clinical trials represent a selection of key studies that are currently recruiting patients with lupus for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials. Read More ›